Supplementary figures (frontal fibrosing alopecia)

Published: 23-11-2019| Version 8 | DOI: 10.17632/5ws4pj9pfr.8
Ali Nili,
maryam daneshpazhooh,
Hamid Reza Mahmoudi


title : Isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: A randomized clinical trial Isotretinoin combined with topical treatments can be a more effective therapeutic option than monotherapy with clobetasol and tacrolimus for FFA.


Steps to reproduce

Between November 2017 and August 2018, selected FFA patients were randomly assigned to receive either isotretinoin (20mg/d) plus topical treatments (clobetasol 0.05% and tacrolimus 0.1%) or monotherapy with topical treatments. Treatments’ efficacy was evaluated through Frontal Fibrosing Alopecia Severity Index (FFASI) after two and six months.